Viewing Study NCT06846606


Ignite Creation Date: 2025-12-26 @ 5:19 PM
Ignite Modification Date: 2026-03-02 @ 7:00 PM
Study NCT ID: NCT06846606
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Sponsor: Auron Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module